Koyfin Home > Directory > Health Care > Oxford Immunotec > Gross Profit

Oxford Immunotec Gross Profit Chart (OXFD)

Oxford Immunotec annual/quarterly Gross Profit from 2012 to 2020. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Oxford Immunotec Gross Profit for the quarter ending September 09, 2020 was $15m a 4.53% increase of 1m year over year
  • Oxford Immunotec Gross Profit for the last 12 months ending September 09, 2020 was $43m a -26.52% decrease of -11m year over year
  • Oxford Immunotec Annual Gross Profit for 2019 was $54m a 21.12% increase of 11m from 2018
  • Oxford Immunotec Annual Gross Profit for 2018 was $43m a 15.52% increase of 7m from 2017
  • Oxford Immunotec Annual Gross Profit for 2017 was $36m a 15.90% increase of 6m from 2016
Other Income Statement Metrics:
  • Oxford Immunotec EBITDA for the quarter ending December 12, 2018 was $-2m a -283.29% increase of 6m year over year
  • Oxford Immunotec Net Income for the quarter ending December 12, 2018 was $142m a 107.29% increase of 152m year over year
  • Oxford Immunotec Total Revenue for the quarter ending September 09, 2018 was $16m a -55.93% decrease of -9m year over year
View Chart On Koyfin

Quarterly OXFD Gross Profit Data

09/2020$15m
06/2020$4m
03/2020$10m
12/2019$14m
09/2019$15m
06/2019$14m
03/2019$11m
12/2018$11m
09/2018$11m
06/2018$12m

Annual OXFD Gross Profit Data

2019$54m
2018$43m
2017$36m
2016$30m
2015$33m
2014$25m
2013$20m
2012$8m
2011$4m